Please login to the form below

Not currently logged in
Email:
Password:

Sanofi Pasteur raises polio awareness

Sanofi-aventis division to raise awareness of polio with stock exchange 'bell-ringing'

Sanofi Pasteur, the vaccines division of the sanofi-aventis group, is to raise awareness of the efforts made to eradicate polio by participating in bell-ringing events for stock exchanges across the globe. Bell-ringing is used to signify the opening and closing of a day's trading.

Sanofi said the events are to acknowledge 'past successes and future challenges in the battle to eradicate polio', with participating stock exchanges including New York, Paris, Brussels, Amsterdam and Lisbon.

The company said: "Sanofi Pasteur stands shoulder to shoulder with Rotary International, the World Health Organization (WHO), the Bill and Melinda Gates Foundation and the myriad of other organisations that are engaged in this critical effort to save lives. As a pioneer and leader in the development of polio vaccine the company stands behind all efforts that will eradicate the disease."

Sanofi Pasteur has supported the Global Polio Eradication Initiative (GPEI) since its launch in 1988. GPEI's spearheading partners are Rotary International, the WHO, the US Centers for Disease Control and Prevention and UNICEF. The company has provided more than five billion doses of polio vaccine worldwide.

24th February 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

ema1
The European Medicines Agency: PRIME’d for access?
Leela Barham examines the impact of the EMA's PRIME fast track system after two years...
How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...

Infographics